Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/28896
Title: | Durable Efficacy and Safety With Alemtuzumab in CARE-MS I Patients Switching From SC IFNB-1a: 5-Year Follow-up (TOPAZ Study) | Authors: | Steingo, Brian Oreja-Guevara, Celia Alroughani, Raed Brassat, David Boyko, Alexey N. McCombe, Pamela VAN WIJMEERSCH, Bart Margolin, David H. Melanson, Maria Daizadeh, Nadia Rodriguez, Claudio E. Vermersch, Patrick |
Issue Date: | 2018 | Publisher: | LIPPINCOTT WILLIAMS & WILKINS | Source: | NEUROLOGY, 90(15) (Art N° P6.376) | Notes: | [Steingo, Brian] Ft Lauderdale Multiple Sclerosis Ctr, Ft Lauderdale, FL USA. [Oreja-Guevara, Celia] Univ Hosp San Carlos, Madrid, Spain. [Alroughani, Raed] Amiri Hosp, Sharq, Kuwait. [Brassat, David] Univ Toulouse, Purpan Hosp, Toulouse, France. [Brassat, David] Univ Toulouse, Mixed Unit Res 1043, Toulouse, France. [Boyko, Alexey N.] Pirogov Russian Natl Res Univ, Moscow, Russia. [Boyko, Alexey N.] Usupov Hosp, Demyelinating Dis Ctr, Moscow, Russia. [McCombe, Pamela] Univ Queensland, Brisbane, Qld, Australia. [Van Wijmeersch, Bart] Hasselt Univ, Rehabil, Hasselt, Belgium. [Van Wijmeersch, Bart] Hasselt Univ, MS Ctr Overpelt, BIOMED, Hasselt, Belgium. [Margolin, David H.; Melanson, Maria; Daizadeh, Nadia; Rodriguez, Claudio E.] Sanofi, Cambridge, MA USA. [Vermersch, Patrick] Univ Lille, Lille, France. | Document URI: | http://hdl.handle.net/1942/28896 | ISSN: | 0028-3878 | e-ISSN: | 1526-632X | ISI #: | 000453090805102 | Rights: | 2018, American Academy of Neurology | Category: | M | Type: | Journal Contribution |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Schmidtea mediterranea as an alternative model to predict carcinogenicity via its stem cell responses _ Elsevier Enhanced Reader.pdf Restricted Access | Published version | 712.7 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.